Loading...

Target Malaria Uganda Press Kit

A group photo of the Target Malaria Uganda Team

Target Malaria Uganda Logo

Malaria, a public health burden in Uganda

Malaria is still a public health burden in Uganda, accounting for 12,6 million infections and about 15,945 deaths yearly as shown by the World Health Organization’s (WHO) 2024 World Malaria Report.

Malaria places a heavy burden on Uganda’s public health system and economy. 90% of Uganda’s population is at risk of malaria infection. Uganda is one of the 11 African countries concentrating two thirds of global malaria cases and deaths: Burkina Faso, Cameroon, Democratic Republic of the Congo, Ghana, Mali, Mozambique, Niger, Nigeria, Sudan, United Republic of Tanzania and Uganda. Sub-Saharan Africa is still the most affected by malaria, with 90% of cases globally. However, despite significant progress the past decades, efforts to combat malaria are stalling.

Existing methods to combat malaria, such as insecticide-treated nets, insecticides, and antimalarial drugs, have helped tremendously to reduce the malaria problem in Africa but, unfortunately, are not enough to eradicate malaria from Africa.

Various types of research are carried out to contribute to eliminating malaria by 2030, as advocated by WHO in its global technical strategy document for the fight against malaria 2016-2030, and Target Malaria is part of this effort.

Target Malaria Uganda is located in Entebbe, at the Uganda Virus Research Institute (UVRI), an institute specialising in health research on human infections and disease processes associated with or linked to viral aetiology.

With all regulatory approvals in place, Target Malaria successfully  imported the non gene drive male bias mosquito in May 2024  to conduct contained studies on the UVRI campus in Entebbe. This is an important milestone for Target Malaria’s work in Uganda. It is also the first importation and research on genetically modified mosquitoes in Uganda.

Photos & Videos​

Media coverage